From: Scaffold-based delivery of mesenchymal stromal cells to diabetic wounds
Scaffold formation | Material | Cell type | Animal model | Outcome | Possible mechanism | References |
---|---|---|---|---|---|---|
Hydrogel scaffold | Collagen type I | Mouse BM-MSCs and AD-MSCs | STZ-induced diabetic C57BL/6 mouse | Murine BM-MSCs and AD-MSCs are equivalent at enhancing wound healing | MSC treatment improve wound healing by increasing VEGF-A expression, cellular proliferation, endothelial cell density, numbers of macrophages and smooth muscle cells and upregulating Notch signalling | Guo et al. [57] |
Hydrogel scaffold | Collagen type I | Mouse BM-MSCs | STZ-induced diabetic C57BL/6 mouse | Transplantation of rolled scaffolds containing BM-MSC increased wound healing, cellular proliferation and capillary density as well as increased number of macrophages, fibroblasts and smooth muscle cells | Scaffolds in a rolled formation, were hypoxia, induced MSC secrete VEGF | Assi et al. [56] |
Hydrogel scaffold | PEGDA and gelatin | Mouse AD-MSCs | db/db diabetic mouse | AD-MSC embedded hydrogel significantly accelerated diabetic wound healing | Hydrogel-mediated delivery of AD-MSCs accelerated wound closure by supressing infiltration of inflammatory cells (macrophages and T cells) and enhancing neovascularization | Dong et al. [59] |
Hydrogel scaffold | N-isopropylacrylamide and poly (amidoamine) | Mouse BM-MSCs | db/db diabetic mouse | Promoted granulation tissue formation, angiogenesis, ECM secretion, wound contraction, and re-epithelialization | Hydrogel promoted BM-MSC secretion of TGFβ-1 and bFGF, inhibited pro-inflammatory M1 macrophage expression | Chen et al. [60] |
Hydrogel scaffold | Pluronic F-127 | Rat AD-MSCs | STZ-induced diabetic Sprague Dawley rat | AD-MSC-hydrogel enhanced angiogenesis and cell proliferation at the wound site, accelerated wound closure | Upregulated expression of VEGF and TGFβ-1 play a key role in matrix deposition, cellular migration and wound healing | Kaisang et al. [62] |
Hydrogel scaffold | Silk fibroin, chitosan | Rat AD-MSCs | STZ-induced diabetic Sprague Dawley rat | Wound closure rate increased. Neovascularization improved | AD-MSCs engrafted in hydrogel scaffold promoted the secretion level of EGF, TGF-β, VEGF in the diabetic wound bed | Wu et al. [63] |
Hydrogel scaffold | POLY(β-aminoester)-tetraaniline, HA, gelatin, laccase | AD-MSCs (unknown species) | STZ-induced diabetic Sprague Dawley rat | AD-MSC encapsulated hydrogel enhanced vascular regeneration and immunoregulation in diabetic wound bed, promoted the reconstruction of blood vessels, hair follicles and dermal collagen matrix | AD-MSCs encapsulated in hydrogel exhibited upregulated expression of HIF-1a and connexin 43 | Jin et al. [66] |
Hydrogel scaffold | HA and PEGDA | AD-MSCs (species unknown) | STZ-induced diabetic Sprague Dawley rat | Improved diabetic wound healing process, enhanced angiogenesis and re-epithelialization | Hydrogel maintained the stemness and secretion abilities of AD-MSCs | Xu et al. [67] |
Hydrogel scaffold | Chitosan and HA | Rat BM-MSCs | STZ-induced diabetic Sprague Dawley rat | Promoted granulation tissue formation, collagen deposition, cell proliferation, neovascularization and enhanced diabetic wound healing | The secretion of growth factors (TGF-β1, VEGF and bFGF) from BM-MSCs were increased, hydrogel regulated the inflammatory environment via modulating the macrophages polarization | Bai et al. [64] |
Hydrogel scaffold | Chitosan, polyvinyl alcohol, S-nitroso-N-acetylpenicillamine (SNAP) | Rabbit BM-MSCs | Alloxan-induced diabetic rabbit | SNAP-loaded hydrogel combined with BM-MSC significantly improved wound healing rate, re-epithelialization and collagen deposition | The gene-expression of VEGF and SDF-1a were significantly upregulated in wounds treated with BM-MSCs embedded in Nitric-oxide-releasing hydrogels | Ahmed et al. [65] |
Hydrogel scaffold | HA | Human AD-MSCs | db/db diabetic mouse | AD-MSC promoted wound closure and accelerated epithelialization | Stem cell markers (NANOG, OCT3/4, SOX-2 and SSEA-3) were up-regulated in AD-MSC microgel | Feng et al. [68] |
Hydrogel scaffold | Gellan gum and HA | Human AD-MSCs | STZ-induced diabetic CD1-ICR mouse | AD-MSCs treatment resulted in re-epithelialization, thicker and more differentiated epidermis on wound bed | AD-MSCs treatment improve wound healing via modulating the inflammatory response during proliferative phase of wound healing to promote a successful neovascularization | Da silva et al. [70] |
Hydrogel scaffold | Decellularized adipose matrix | Human AD-MSCs | KK/Upj-Ay/J mouse (Diabetic mouse) | Accelerated wound closure and increased neovascularization | Decellularized adipose matrix supported hAD-MSCs survival and proliferation, enhanced paracrine activity and increased secretion of HGF | Chen et al. [71] |
Hydrogel scaffold | HyStem®-HP hydrogel | VEGFA hyper secreted human BM-MSCs | db/db diabetic mouse | Improved wound healing rate in wounds treated with VEGFA hyper secreted hBM-MSCs | N/A | Srifa et al. [72] |
Hydrogel scaffold | PEGDA, 1-vinyl-2-pyrrolidinone, eosin Y | Rat ISCs and human BM-MSCs | db/db diabetic mouse | ISC:MSC combination group accelerate diabetic wound healing almost 3 times faster than control group (14 vs. ~ 40 days), without intermediate scab or scar | Co-encapsulation of ISC and BM-MSC in hydrogel improved wound healing by secreting insulin, VEGF, and TGFβ-1. The viability and function of MSC improved due to activation of the PI3K-Akt/PKB pathway | Aijaz et al. [73] |
Sponge scaffold | Collagen type I | Rabbit BM-MSCs | Alloxan-induced diabetic rabbit | Collagen BM-MSC treatment promoted wound closure and angiogenesis in diabetic rabbit ulcer | Increased total length of blood vessels with enhanced neovascularization in collagen BM-MSC group | O’Loughlin et al. [79] |
Sponge scaffold | Collagen, chitosan | Rat BM-MSCs | STZ-induced diabetic Wistar rat | BM-MSC treatment accelerated wound closure in diabetic rat | Hypoxia pre-treated BM-MSC increased the expression of HIF-1a, VEGF, and PDGF, promoted wound closure via reducing inflammation and enhancing angiogenesis in diabetic wound bed | Tong et al. [80] |
Sponge scaffold | Chitosan, collagen, nanostructured lipid carriers, simvastatin | Rat epidermal MSCs | STZ-induced diabetic Wistar rat | Increased wound closure rate, promoted vascularization, enhanced viability and proliferation of stem cells | Sponge scaffolds provide a microenvironment suitable for cell proliferation, molecules transmission, and a controlled release of simvastatin | Örgül et al. [82] |
Sponge scaffold | Chitosan and polyurethane | Rat AD-MSCs | STZ-induced diabetic Sprague Dawley rat | MSC-scaffold bio-complex and acupuncture treatment improved wound closure (90.34 ± 2.3%), completely re-epithelialized in 8 days | The combined treatment of MSC-scaffold bio-complex and acupuncture on wounds produced synergistic immunomodulatory effects via activating C3a and C5a, up-regulating the secretion of cytokines SDF-1 and TGF β-1, and downregulating proinflammatory cytokines TNF-α and IL-1β | Chen et al. [83] |
Sponge scaffold | Curcumin, chitosan, alginate, EGF | Mouse BM-MSCs | STZ-induced diabetic Sprague Dawley rat | BM-MSCs delivered by Curcumin-EGF scaffold significantly improved wound closure by increasing granulation tissue formation, collagen deposition and angiogenesis | The scaffold enhanced BM-MSC viability and expression of transcription factors associated with the maintenance of pluripotency and self-renewal (OCT3⁄4, SOX2, and Nanog) | Mohanty et al. [84] |
Fibrous scaffold | Polycaprolactone, pluronic-F-127, gelatin | Mouse BM-MSCs | TALLYHO type 2 diabetic mouse | BM-MSC engraftment enhanced granulation tissue formation, promoted angiogenesis and collagen deposition in diabetic wound site | The BM-MSC engraftment inhibited the formation of M1-type macrophages and expression of pro-inflammatory cytokines (IL-6, TNF-α), promoted formation of M2-type macrophages and expression of anti-inflammatory cytokines (IL-4, IL-10) in the diabetic wound | Chen et al. [92] |
Fibrous scaffold | Polylactic acid, silk and collagen | Human BM-MSCs | STZ-induced C57BL/6 J diabetic mouse | HO-1-overexpressing human BM-MSCs-scaffold complex significantly promote angiogenesis and wound healing | Over-expression of HO-1 promoted the proliferation and paracrine (e.g. VEGF) activity of BM-MSC via Akt signalling pathway | Hou et al. [93] |
Fibrous scaffold | Polylactic acid, silk and collagen | Human BM-MSCs | STZ-induced C57BL/6 J diabetic mouse | Wound healed prominently, more blood vessel formation | Brain-derived neurotrophic factor activated MSCs differentiate into endothelial cells and accelerated wound healing | He et al. [94] |
Fibrous scaffold | Aloe vera, polycaprolactone | Human UC-MSCs | db/db diabetic mouse | Diabetic wounds showed rapid wound closure, re-epithelialization and increased number of sebaceous glands and hair follicles | After treatment, the wounds showed positive keratinocyte markers (cytokeratin, involucrin, filaggrin) and increased expression of ICAM-1, TIMP-1, and VEGF-A | Tam et al. [95] |
Fibrous scaffold | Silk fibroin | Human AD-MSCs | db/db diabetic mouse | Both AD-MSCs-SF and decellularized AD-MSCs-SF significantly enhanced wound closure, completing the process in around 10 days as compared to 15–17 days in control group | SF bind angiogenic factors (bFGF and TGF-β) produced by AD-MSCs; AD-MSCs-SF stimulate hUVECs migration through release of VEGF; Enhanced ECM deposition, angiogenesis and immunomodulation; Down-regulated inflammatory gene expression (Mif and Il6st) | Navone et al. [96] |
Decellularized graft | Cadaveric skins of human donors | Rat AD-MSCs | STZ-induced diabetic Sprague Dawley rat | AD-MSCs-scaffold treatment significantly enhanced wound closure and epithelialization | AD-MSCS secreted angiogenic growth factors (VEGF, HGF, TGFβ and bFGF) resulting in accelerated wound healing | Nie et al. [111] |
Decellularized graft | IRC mouse skin | Mouse BM-MSCs | Diabetic ICR mouse | BM-MSC-decellularized graft increased angiogenesis and reepithelialisation on diabetic wound bed | BM-MSCs-scaffold treatment enhanced synthesis of collagen type I during wound healing, increased epidermal thickness and vessel density | Chu et al. [98] |
Decellularized graft | IRC mouse skin | Mouse BM-MSCs | STZ-induced IRC mouse | Induced robust vascularization and collagen deposition and rapid re-epithelialization | Scaffolds provide a microenvironment for cell attachment, migration and proliferation | Fu et al. [112] |
Decellularized graft | Porcine skin, collagen, and chitosan | Human UC-MSCs | STZ-induced diabetic Sprague Dawley rat | UC-MSC delivered by decellularized graft significantly improved wound healing | Therapeutic effect of UC-MSCs on diabetic wound significantly enhanced by the activation of Wnt signalling pathway | Han et al. [113] |